Global Alzheimer’s Drugs Market: Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

“The Report Alzheimer’s Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

About  Alzheimer’s Drugs Market

This report on the Alzheimer’s drugs market analyzes the current and future scenario of the global market. Increasing prevalence of Alzheimer’s, innovation in the development of new drugs, biomarker analysis and most promising molecules analysis, drug class sales during the forecast period.

Global Alzheimer’s Drugs Market: Research Methodology

The global Alzheimer’s drugs market report contain an elaborate executive summary, which includes following points such as market snapshot that provides information about various segments globally. It also comprise information and data analysis of the country’s market with respect to the segments based on drug class type, distribution channels and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises PEST Analysis, Porters Five Forces Analysis and Pipeline Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global Alzheimer’s drug market.

Global Alzheimer’s Drugs Market: Segmentation

Based on drug class, the market has been segmented into four major drug class such as cholinergic, memantine, combined drugs, and others. The market segments have been analyzed based on available approved products, cost-effectiveness. All segments market size and forecast has been presented for the period from 2017 to 2025, 2016 consider as a base year for this report.

Get Sample copy of this Report @

As per distribution channels, the global Alzheimer’s drugs market has been segmented into three segments including hospital pharmacy, retail pharmacy, and online sales. All market segmentations has been analyzed based on increasing demand for disease treatment. Increased patient hospitalization for the treatment of Alzheimer’s are driving the market share of hospital pharmacy segment. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also comprise the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, Alzheimer’s drugs market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been presented for the period from 2015 to 2025. CAGR for all segments has been presented for the period from 2017 to 2025, 2016 consider as a base year for this report.

Global Alzheimer’s Drugs Market: Competitive Dynamics

The report also profiles major key players in the Alzheimer’s drugs market based on various attributes such as company overview, product portfolio, financial overview, business strategies, recent developments and company SWOT analysis. Major players operating in the Alzheimer’s drug market included in this report are Allergan plc, Novartis AG, Eisai Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited, Ono Pharmaceutical Co Ltd, Merz Holding GmbH & Co KG, and Johnson & Johnson.

Global Alzheimer’s Drugs Market is segmented as below:

Global Alzheimer’s Drug Market, by Drug Class



Combined Drug


Global Alzheimer’s Drug Market, by Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Sales

Global Alzheimer’s Drug Market, by Geography

North America









Rest of Europe

Asia Pacific




Australia & New Zealand

Rest of Asia Pacific

Latin America



Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East & Africa

Table of Content

Chapter 1 Preface

1.1 Report Scope and Market Segmentation

1.2 Research Highlights

Chapter 2 Assumptions and Research Methodology

2.1 Assumptions

2.2 Research Methodology

View Sample PDF @

Chapter 3 Executive Summary

3.1 Alzheimer’s Drugs Market Snapshot, 2016

3.2 Alzheimer’s Drugs Market: Opportunity Map

Chapter 4 Market Overview

4.1 Introduction

4.2 Global Alzheimer’s Drugs Market Size (US$ Mn) Forecast, 2015–2025

4.3 Alzheimer’s Drugs Market Outlook

4.4 Key Industry Events

Chapter 5 Market Dynamics

5.1 Drivers and Restraints Snapshot Analysis

5.2 Drivers

5.2.1 Increasing global prevalence of Alzheimer’s

5.2.2 Improvising regulatory scenario

5.2.3 Increasing government funding

5.2.4 Entry of novel symptomatic therapies

5.2.5 Growing social awareness of the disease

5.3 Restraints

5.3.1 Alzheimer’s drug failure rate at 99%

5.3.2 Multifactorial etiology and complex pathophysiology of the disease

5.3.3 High level of comorbidity occurring in the elderly population

5.3.4 Expanding diagnostic capability

5.3.5 Increasing cost for Alzheimer’s drug development

5.4 Opportunities

5.4.1 Reduce the time and risk of AD drug development through an improvement in trial design

5.4.2 Improving clinical outcomes

5.5 Trends

5.5.1 Development of compounds acting on the main stages of the pathogenesis of the disease (disease-modifying agents

5.5.2 Focused design of multi targeted drugs acting on multiple molecular targets involved in the pathogenesis of the disease

5.6 Porter’s Five Forces Analysis

5.7 PEST Analysis

5.8 Pipeline Analysis

5.9 Global Prevalence & Incidence

5.10 Biomarkers Analysis

5.11 Most Promising Molecules

Send An Enquiry Request @

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074



Designed by
Powered by